Today: 19 January 2026
Subscribe
Browse Category

Mergers & Acquisitions News 8 November 2025 - 11 November 2025

Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance Corporation reported its first results since the Skydance–Paramount merger and the stock rallied after management laid out a bigger streaming-and-studios investment plan and raised its cost‑savings target. Shares were up ~5.5% today as CEO David Ellison emphasized a tech‑forward overhaul, a fatter content slate, and a sharper path to profitability. Reuters Quick take (today) What happened on November…
11 November 2025
····
Kaltura (KLTR) soars as Q3 beats, $27M eSelf.ai deal lands, and 14.4M-share buyback headlines — Nov. 11, 2025

Kaltura (KLTR) soars as Q3 beats, $27M eSelf.ai deal lands, and 14.4M-share buyback headlines — Nov. 11, 2025

What’s new today (Nov. 11, 2025) Shares surge after Q3 + AI deal headlines. KLTR is one of today’s bigger software movers. Benzinga’s pre‑market screen flagged KLTR up ~26.5% to $1.86 before the bell following last night’s results and acquisition news; live prices show the rally continuing after the open. Benzinga Local tech press amplifies the acquisition. Israeli outlet CTech…
11 November 2025
····
C3.ai (AI) shares edge higher as company explores sale — everything new on November 11, 2025

C3.ai (AI) shares edge higher as company explores sale — everything new on November 11, 2025

C3.ai, Inc. (NYSE: AI) is in the spotlight today after a late‑Monday Reuters exclusive said the enterprise‑AI software maker is exploring a potential sale as part of a broader strategic review following its recent leadership transition. Additional outlets echoed the report overnight in Asia and Europe, and traders are watching for follow‑on headlines ahead of the company’s next earnings date…
11 November 2025
····
Shiseido cuts 2025 outlook to ¥52bn net loss, books ¥46.8bn Americas impairment and launches 200‑person voluntary exit

Shiseido cuts 2025 outlook to ¥52bn net loss, books ¥46.8bn Americas impairment and launches 200‑person voluntary exit

Tokyo — November 10, 2025 Japan’s Shiseido Co. (TSE: 4911) slashed its full‑year guidance and flagged deeper restructuring, warning it now expects a ¥52 billion net loss for the year to December 31, 2025 (IFRS), versus a previous forecast for a ¥6 billion profit. The cosmetics group cited a goodwill impairment in the Americas and softer demand as it also…
10 November 2025
···
Axia Energia debuts AXIA3; court declares Oi bankrupt; Kepler Weber gets R$11 offer — Brazil market wrap (Nov 10)

Axia Energia debuts AXIA3; court declares Oi bankrupt; Kepler Weber gets R$11 offer — Brazil market wrap (Nov 10)

São Paulo — November 10, 2025. Key points Axia Energia: new tickers on B3 and NYSE Axia Energia—Eletrobras’ new name—debuted its tickers on B3 this Monday: AXIA3 (common), AXIA5 (preferred A) and AXIA6 (preferred B). On the NYSE, the company’s ADRs now trade as AXIA (common) and AXIA PR (preferred), replacing EBR and EBR.B. Axia marked the change with a…
10 November 2025
···
Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Shares of Metsera, Inc. (NASDAQ: MTSR) slumped on Monday after the obesity‑drug developer said it will proceed with a sweetened takeover by Pfizer that ends a high‑stakes bidding war with Novo Nordisk. Metsera accepted Pfizer’s revised offer late Friday; Novo dropped out over the weekend. In early U.S. trading today, MTSR fell ~15% as investors recalibrated expectations around the final…
10 November 2025
···
Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

What Happened Movano Inc. (NASDAQ: MOVE) and Corvex, Inc., a GPU‑accelerated AI cloud company, signed a definitive all‑stock merger agreement. The combined business will focus squarely on secure, high‑performance AI infrastructure—including GPU clusters for training/inference, confidential computing, and inference‑as‑a‑service—repositioning Movano away from consumer health wearables. Upon closing, “Movano Inc.” will be renamed “Corvex, Inc.” and move its headquarters to Arlington,…
10 November 2025
····
Ondas Holdings (ONDS) names ex‑Rafael chief Yoav Har‑Even to OAS advisory board as Sentrycs acquisition advances — Nov. 10, 2025

Ondas Holdings (ONDS) names ex‑Rafael chief Yoav Har‑Even to OAS advisory board as Sentrycs acquisition advances — Nov. 10, 2025

Ondas Holdings Inc. (NASDAQ: ONDS) announced that Maj. Gen. (Ret.) Yoav Har‑Even, former President & CEO of Rafael Advanced Defense Systems, has joined the advisory board of Ondas Autonomous Systems (OAS), the company’s defense and security robotics unit. The move adds a veteran of multi‑domain operations and large defense programs to OAS at a time when Ondas is expanding its…
10 November 2025
··
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Novo Nordisk and Pfizer Stocks Today (Nov. 10, 2025): Pfizer Clinches $10B Metsera Deal as Novo Rises on Exit and India Brand Move

Published: November 10, 2025 Summary: On Monday, Pfizer said it will acquire obesity‑drug developer Metsera in a deal worth up to $10 billion, while Novo Nordisk shares climbed after bowing out of the bidding war. Governance drama around Novo’s board intensified as Norway’s $1.5 trillion sovereign wealth fund said it would abstain from key votes this week. Separately, Novo struck…
10 November 2025
···
Pandox Completes €1.7bn Dalata Takeover: Dalata Delists Today as Scandic Takes Over 56 Hotels (10 Nov 2025)

Pandox Completes €1.7bn Dalata Takeover: Dalata Delists Today as Scandic Takes Over 56 Hotels (10 Nov 2025)

Published: 10 November 2025 Summary: Dalata Hotel Group plc has been formally delisted this morning following the completion of its acquisition by a Pandox AB–Eiendomsspar AS consortium. Scandic Hotels Group has begun managing Dalata’s 56 hotels under an interim management agreement and intends to acquire the operating platform for €500 million after a carve‑out, while Pandox will retain 31 investment…
10 November 2025
···
Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Financing & balance sheet: euro notes + tender offer Bristol‑Myers Squibb priced €5 billion in senior unsecured notes across five tranches — €750M 2030 (2.973%), €1.15B 2033 (3.363%), €1.15B 2038 (3.857%), €750M 2045 (4.289%), and €1.2B 2055 (4.581%) — with closing anticipated Nov. 10, 2025. The notes are guaranteed by Bristol‑Myers Squibb Company. Bristol Myers Squibb News Proceeds, plus about…
9 November 2025
····
Metsera (NASDAQ: MTSR): Pfizer Clinches $10B Deal as Novo Nordisk Bows Out — What to Know Today (Nov. 8, 2025)

Pfizer Clinches $10B Takeover of Metsera as Novo Nordisk Bows Out — Full Terms, Timeline, and What It Means (Nov. 8, 2025)

Metsera (NASDAQ: MTSR) and Pfizer struck an amended deal worth up to $10B after Novo Nordisk exited the bidding. Here are the final terms, key dates, and what investors should watch next. Updated: November 8, 2025 Top takeaways What changed on Nov. 7–8 Friday, Nov. 7: Metsera announced an amended merger agreement with Pfizer at $86.25 per share (comprised of…
8 November 2025
···
1 … 23 24 25 26 27 … 34

Stock Market Today

  • Nasdaq-Listed eToro to Add Singapore Exchange Stocks in Asia Expansion
    January 18, 2026, 6:17 PM EST. Nasdaq-listed investment platform eToro is intensifying its focus on the Asia-Pacific market by adding stocks from the Singapore Exchange (SGX) later this year. This move extends eToro's international equity offerings, which already include major global exchanges such as New York, London, Hong Kong, Euronext, and Dubai. The company aims to use Singapore as a regional hub to expand across Southeast Asia. CEO Yoni Assia confirmed this strategy, highlighting Singapore's role in eToro's long-term growth plan. The addition of SGX stocks is part of eToro's broader push to tap into the fast-growing Asian market and diversify its platform's asset access.
Go toTop